Efficacy of the Novel Degludec/Aspart Insulin Co-formulation in Children and Adolescents with Type 1 Diabetes: A Real-life Experience with One Year of IDegAsp Therapy in Poorly Controlled and Non-compliant Patients

• Главные авторы: Tarık Kırkgöz (Автор), Mehmet Eltan (Автор), Sare Betül Kaygusuz (Автор), Zehra Yavaş Abalı (Автор), Didem Helvacıoğlu (Автор), Tuba Seven Menevşe (Автор), Büşra Gürpınar Tosun (Автор), Tülay Güran (Автор), Abdullah Bereket (Автор), Serap Demircioğlu (Автор)
• Формат: ‌
• Опубликовано: Galenos Yayincilik, 2022-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

INTRODUCTION: To evaluate the efficacy of degludec/aspart (IDegAsp) insulin co-formulation in children and adolescents with poorly controlled type 1 diabetes (T1DM). METHODS: Patients with poorly controlled T1DM on basal-bolus insulin regimes and having compliance problems related to insulin injecti...